← FDA DRUG APPROVALS

FDA ANDA · ANDA083877

HYDROSERPINE PLUS (R-H-H)

Sponsor: IVAX SUB TEVA PHARMS

APPLICATION
ANDA083877
TYPE
ANDA
ORIGINAL APPROVAL
1975-09-18
LATEST ACTION
1975-09-18
ROUTE
ORAL
DOSAGE FORM
TABLET
MARKETING STATUS
Discontinued

Products

HYDROSERPINE PLUS (R-H-H)Discontinued
HYDRALAZINE HYDROCHLORIDE 25MG, HYDROCHLOROTHIAZIDE 15MG, RESERPINE 0.1MG · TABLET · ORAL

Approval history

1975-09-18OriginalAP
VIEW ON DRUGS@FDA ↗

Related on SPEQ

Pharma industryGMP disciplineFDA drug shortagesFDA enforcement & recalls

Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.

Weekly Briefing

Get the Weekly GxP Briefing

Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.

Read a past issue →